BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lou B, Liao XL, Wu MP, Cheng PF, Yin CY, Fei Z. High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells. World J Gastroenterol 2005; 11(7): 954-959 [PMID: 15742395 DOI: 10.3748/wjg.v11.i7.954]
URL: https://www.wjgnet.com/1007-9327/full/v11/i7/954.htm
Number Citing Articles
1
Lindsay M. Scheetz, Minzhi Yu, Dan Li, María G. Castro, James J. Moon, Anna Schwendeman. Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon AdenocarcinomaInternational Journal of Molecular Sciences 2020; 21(5): 1777 doi: 10.3390/ijms21051777
2
Ke Li, Xianwei Xie, Yansong Guo. HDL Metabolism and DiseasesAdvances in Experimental Medicine and Biology 2022; 1377: 171 doi: 10.1007/978-981-19-1592-5_14
3
Ian R. Corbin, Kenneth Ng, Gang Zheng. Nanoplatform‐Based Molecular Imaging2011; : 431 doi: 10.1002/9780470767047.ch18
4
Zhong-Cheng Mo, Kun Ren, Xing Liu, Zhen-Li Tang, Guang-Hui Yi. A high-density lipoprotein-mediated drug delivery systemAdvanced Drug Delivery Reviews 2016; 106: 132 doi: 10.1016/j.addr.2016.04.030
5
Alexander Pochert, Ina Vernikouskaya, Felix Pascher, Volker Rasche, Mika Lindén. Cargo-influences on the biodistribution of hollow mesoporous silica nanoparticles as studied by quantitative 19F-magnetic resonance imagingJournal of Colloid and Interface Science 2017; 488: 1 doi: 10.1016/j.jcis.2016.10.085
6
Wen-Li Zhang, Xiao Gu, Hui Bai, Ru-Hui Yang, Chen-Dong Dong, Jian-Ping Liu. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drugInternational Journal of Pharmaceutics 2010; 391(1-2): 313 doi: 10.1016/j.ijpharm.2010.03.011
7
Daniel A. Bricarello, Jennifer T. Smilowitz, Angela M. Zivkovic, J. Bruce German, Atul N. Parikh. Reconstituted Lipoprotein: A Versatile Class of Biologically-Inspired NanostructuresACS Nano 2011; 5(1): 42 doi: 10.1021/nn103098m
8
José Medina-Echeverz, Marcos Vasquez, Celia Gomar, Nuria Ardaiz, Pedro Berraondo. Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cellsCancer Immunology, Immunotherapy 2015; 64(6): 717 doi: 10.1007/s00262-015-1681-9
9
Jingting Jiang, Peter Nilsson-Ehle, Ning Xu. Influence of liver cancer on lipid and lipoprotein metabolismLipids in Health and Disease 2006; 5(1) doi: 10.1186/1476-511X-5-4
10
Jing-ting Jiang, Ning Xu, Xiao-ying Zhang, Chang-ping Wu. Lipids changes in liver cancerJournal of Zhejiang University SCIENCE B 2007; 8(6): 398 doi: 10.1631/jzus.2007.B0398
11
Wen-Jun Shen, Salman Azhar, Fredric B. Kraemer. SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and EffluxAnnual Review of Physiology 2018; 80(1): 95 doi: 10.1146/annurev-physiol-021317-121550
12
Wen-Li Zhang, Yan Xiao, Jian-Ping Liu, Zi-Mei Wu, Xiao Gu, Yi-Ming Xu, Hui Lu. Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell modelInternational Journal of Pharmaceutics 2011; 419(1-2): 314 doi: 10.1016/j.ijpharm.2011.07.039
13
Sara Samadi, Majid Ghayour‐Mobarhan, Amirhooshang Mohammadpour, Zahra Farjami, Mahla Tabadkani, Mohammad Hosseinnia, Mehri Miri, Motahareh Heydari‐Majd, Mehrane Mehramiz, Majid Rezayi, Gordon A. Ferns, Amir Avan. High‐density lipoprotein functionality and breast cancer: A potential therapeutic targetJournal of Cellular Biochemistry 2019; 120(4): 5756 doi: 10.1002/jcb.27862
14
Mika Lindén. Mesoporous Silica-based Nanomaterials and Biomedical Applications, Part AThe Enzymes 2018; 43: 155 doi: 10.1016/bs.enz.2018.07.007
15
Yujie Zhang, Tao Sun, Chen Jiang. Biomacromolecules as carriers in drug delivery and tissue engineeringActa Pharmaceutica Sinica B 2018; 8(1): 34 doi: 10.1016/j.apsb.2017.11.005
16
Jie Tang, Rui Kuai, Wenmin Yuan, Lindsey Drake, James J. Moon, Anna Schwendeman. Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targetingNanomedicine: Nanotechnology, Biology and Medicine 2017; 13(6): 1869 doi: 10.1016/j.nano.2017.04.009
17
Soo In Kim, Duckhyang Shin, Tae Hyun Choi, Jong Chan Lee, Gi-Jeong Cheon, Ki-Yong Kim, Mahnhoon Park, Meehyein Kim. Systemic and Specific Delivery of Small Interfering RNAs to the Liver Mediated by Apolipoprotein A-IMolecular Therapy 2007; 15(6): 1145 doi: 10.1038/sj.mt.6300168
18
Yang Ding, Wei Wang, Meiqing Feng, Yu Wang, Jianping Zhou, Xuefang Ding, Xin Zhou, Congyan Liu, Ruoning Wang, Qiang Zhang. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapyBiomaterials 2012; 33(34): 8893 doi: 10.1016/j.biomaterials.2012.08.057
19
Michael N. Oda, Peter L. Hargreaves, Jennifer A. Beckstead, Katherine A. Redmond, Rik van Antwerpen, Robert O. Ryan. Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin BJournal of Lipid Research 2006; 47(2): 260 doi: 10.1194/jlr.D500033-JLR200
20
Gamaleldin I. Harisa, Fars K. Alanazi. Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugsSaudi Pharmaceutical Journal 2014; 22(6): 504 doi: 10.1016/j.jsps.2013.12.015
21
Nicholas S. Caron, Amirah E.-E. Aly, Hailey Findlay Black, Dale D.O. Martin, Mandi E. Schmidt, Seunghyun Ko, Christine Anderson, Emily M. Harvey, Lorenzo L. Casal, Lisa M. Anderson, Seyed M.R. Rahavi, Gregor S.D. Reid, Michael N. Oda, Danica Stanimirovic, Abedelnasser Abulrob, Jodi L. McBride, Blair R. Leavitt, Michael R. Hayden. Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington diseaseJournal of Controlled Release 2024; 367: 27 doi: 10.1016/j.jconrel.2024.01.011
22
Ian R Corbin, Kenneth K Ng, Lili Ding, Andrea Jurisicova, Gang Zheng. Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriersNanomedicine 2013; 8(6): 875 doi: 10.2217/nnm.12.137
23
R. Kannan Mutharasan, Linda Foit, C. Shad Thaxton. High-density lipoproteins for therapeutic delivery systemsJournal of Materials Chemistry B 2016; 4(2): 188 doi: 10.1039/C5TB01332A
24
Timo Vuorela, Andrea Catte, Perttu S. Niemelä, Anette Hall, Marja T. Hyvönen, Siewert-Jan Marrink, Mikko Karttunen, Ilpo Vattulainen, Helmut Grubmüller. Role of Lipids in Spheroidal High Density LipoproteinsPLoS Computational Biology 2010; 6(10): e1000964 doi: 10.1371/journal.pcbi.1000964
25
Baolong Wang, Yuan Yuan, Lei Han, Li Ye, Xunlong Shi, Meiqing Feng. Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinomaJournal of Drug Targeting 2014; 22(1): 76 doi: 10.3109/1061186X.2013.839687
26
Aditya Gupta, Reena Sharma, Kaushik Kuche, Sanyog Jain. Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructuresInternational Journal of Pharmaceutics 2021; 596: 120272 doi: 10.1016/j.ijpharm.2021.120272
27
Tatsuya Murakami. Phospholipid nanodisc engineering for drug delivery systemsBiotechnology Journal 2012; 7(6): 762 doi: 10.1002/biot.201100508
28
Xiao-Chun Ni, Yong Yi, Yi-Peng Fu, Xiao-Yan Cai, Gao Liu, Jin-Long Huang, Wei Gan, Jie Xu, Shuang-Jian Qiu. <p>Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection</p>OncoTargets and Therapy 2020; : 12867 doi: 10.2147/OTT.S279997
29
Mohammad Mahmoudian, Sara Salatin, Ahmad Yari Khosroushahi. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug deliveryCancer Chemotherapy and Pharmacology 2018; 82(3): 371 doi: 10.1007/s00280-018-3626-4
30
Yijun Mei, Lu Tang, Qiaqia Xiao, Ziqi Zhang, Ziyao Zhang, Jing Zang, Jianping Zhou, Ying Wang, Wei Wang, Min Ren. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapyJournal of Materials Chemistry B 2021; 9(3): 612 doi: 10.1039/D0TB02139C
31
Xiao Gu, Wenli Zhang, Jianping Liu, John P. Shaw, Yuanjun Shen, Yiming Xu, Hui Lu, Zimei Wu. Preparation and Characterization of a Lovastatin-Loaded Protein-Free Nanostructured Lipid Carrier Resembling High-Density Lipoprotein and Evaluation of its Targeting to Foam CellsAAPS PharmSciTech 2011; 12(4): 1200 doi: 10.1208/s12249-011-9668-0
32
Kanita Salic, Leon J. De Windt. MicroRNAs as Biomarkers for Myocardial InfarctionCurrent Atherosclerosis Reports 2012; 14(3): 193 doi: 10.1007/s11883-012-0238-z
33
Kyung-Hyun Cho. High-Density Lipoproteins as Biomarkers and Therapeutic Tools2019; : 77 doi: 10.1007/978-981-13-7383-1_2
34
Nirupama Sabnis, Andras G Lacko. Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeuticsTherapeutic Delivery 2012; 3(5): 599 doi: 10.4155/tde.12.41
35
Susan Sarhadi, Shiva Ganjali, Matteo Pirro, Amirhossein Sahebkar. The role of high‐density lipoproteins in antitumor drug deliveryIUBMB Life 2019; 71(10): 1442 doi: 10.1002/iub.2105
36
Linda K. Mooberry, Nirupama A. Sabnis, Marlyn Panchoo, Bhavani Nagarajan, Andras G. Lacko. Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and ImagingFrontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00466
37
Wen-Hua Wang, Wei-Sheng Liu, Ya-Wen Wang, Yang Li, Li-Fang Zheng, Da-Qi Wang. Self-assembly and cytotoxicity study of waterwheel-like dinuclear metal complexes: The first metal complexes appended with multiple free hydroxamic acid groupsJournal of Inorganic Biochemistry 2007; 101(2): 297 doi: 10.1016/j.jinorgbio.2006.10.002
38
Jessica Fioravanti, Jesús Prieto, Pedro Berraondo. Fusion Protein Technologies for Biopharmaceuticals2013; : 441 doi: 10.1002/9781118354599.ch29
39
Yoshitaka J. Sei, Jungho Ahn, Taeyoung Kim, Eunjung Shin, Angel J. Santiago-Lopez, Seung Soon Jang, Noo Li Jeon, Young C. Jang, YongTae Kim. Detecting the functional complexities between high-density lipoprotein mimeticsBiomaterials 2018; 170: 58 doi: 10.1016/j.biomaterials.2018.04.011
40
Ki-Hoon Park, Chae-Ok Yun, Oh-Joon Kwon, Cheol-Hee Kim, Jae-Ryong Kim, Kyung-Hyun Cho. Enhanced Delivery of Adenovirus, Using Proteoliposomes Containing Wildtype or V156K Apolipoprotein A-I and DimyristoylphosphatidylcholineHuman Gene Therapy 2010; 21(5): 579 doi: 10.1089/hum.2008.207
41
Jessica Fioravanti, Celia Gomar, José Medina‐Echeverz, Itziar Otano, Alberto Benito, Jesús Prieto, Gloria González‐Aseguinolaza, Pedro Berraondo. Characterization of woodchuck apolipoprotein A‐I: A new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis modelJournal of Medical Virology 2011; 83(7): 1221 doi: 10.1002/jmv.22104
42
Peter L. Hargreaves, Thanh-Son Nguyen, Robert O. Ryan. Spectroscopic studies of amphotericin B solubilized in nanoscale bilayer membranesBiochimica et Biophysica Acta (BBA) - Biomembranes 2006; 1758(1): 38 doi: 10.1016/j.bbamem.2006.01.001
43
Vanessa P. M. van Empel, Leon J. De Windt, Paula A. da Costa Martins. Circulating miRNAs: Reflecting or Affecting Cardiovascular Disease?Current Hypertension Reports 2012; 14(6): 498 doi: 10.1007/s11906-012-0310-7
44
Sarah Stanley. Biological nanoparticles and their influence on organismsCurrent Opinion in Biotechnology 2014; 28: 69 doi: 10.1016/j.copbio.2013.11.014
45
Andras G Lacko, Maya Nair, Laszlo Prokai, Walter J McConathy. Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugsExpert Opinion on Drug Delivery 2007; 4(6): 665 doi: 10.1517/17425247.4.6.665